Searched for
KSMS
Anupam Rasayan eyes US, Europe pharma push after Bliss deal, one-third revenue from drugsAnupam Rasayan India Ltd anticipates significant growth in its pharmaceutical segment over the next three years. The company expects pharma...- Swadeshi 1.0 vs. Made in India 2.0: How India turned a 1905 boycott into a 2026 business strategyIndependence Day 2026: From the Swadeshi movement to Atmanirbhar Bharat. Early Swadeshi movements fostered indigenous industries against im...
- Lyfius Pharma Penicillin-G plant inaugurated by PM ModiPrime Minister Narendra Modi virtually inaugurated Lyfius Pharma's Penicillin-G plant in Kakinada, Andhra Pradesh, with a production capaci...
- India all set to make Penicillin G after three decades on PLI pushIndia stopped producing the two input drugs about three decades ago and since then it has relied on China for their supplies. "As of now, w...
- Will India's pharma sector be able to come out of its China dependence?Indian pharma industry's heavy dependence on imports for active pharmaceutical ingredients (API), key starting materials (KSM) and basic ch...
- Investment of Rs 6k cr approved by Centre under PLI scheme for pharma, medical devices sectors: Amit ShahThe Indian government has approved a Rs 6,000 crore ($812 million) investment in the pharmaceutical and medical device manufacturing sector...
- Budget 2023: 'Pharmacy of the world' has a Chinese Achillean heelGiven how crucial the pharmaceutical industry is to the country’s economy, its reliance on China for raw materials is particularly alarming...
- Chinese airlines agree to resume drug imports to IndiaA week after the Chinese state-owned Sichuan Airlines announced suspending its air cargo services to India for 15 days following the second...
- India urges China to clear bottlenecks on key pharma raw-materialThe Pharmexcil director-general Ravi Uday Bhaskar wrote to Indian Ambassador in China Vikram Misri for an immediate intervention in the bac...
- PLI scheme: Government approves 19 applications for domestic manufacturing of APIs, key drug intermediatesFive applications with a committed investment of Rs 3,761 crore have already been approved under Target Segment I, the official statement s...
- Drug companies turn to China, Japan after pricing pressure in westPharma exports likely to cross $19b; value of exports to US market dips.
- Government plans Rs 15,000-crore PLI scheme to boost local drug productionThe scheme intends to promote indigenous manufacture of complex generics, biosimilars and high value-add medicines, to boost domestic drug ...
- Bullish on pharma? 4 big challenges aheadChinese manufacturers have increased the cost of key starting materials (KSMs), or intermediates, by up to 20%, escalating the input cost f...
- China hikes prices of key drug ingredientsWhile increased prices will put cost pressure on the domestic industry over the next few months, more importantly it has sparked speculatio...
- Govt releases guidelines for schemes to boost domestic manufacturing of bulk drugs, med devicesThe schemes—a production-linked incentive (PLI) scheme and industry park scheme each for bulk drugs and medical devices—seek to make India ...
- Boycott China: Checks on imports to hit drug, devices supplyMedical equipment such as infrared thermometers and pulse oximeters needed in the fight against Covid-19, among others, are stuck at the po...
- Remove policy hurdles, grant infrastructure status to bulk drug industry: CII-KPMG reportThe report, 'Indian API Industry- Reaching the Full Potential', by industry body CII and KPMG also recommended granting of infrastructure s...
- Industry players applaud govt's move to boost manufacturing of APIs, med devicesThe approved scheme will promote bulk drug parks for financing common infrastructure facilities in three bulk drug parks with a financial i...
- Coronavirus outbreak: Drug price regulator NPPA calls for close watch on Active Pharmaceutical Ingredients availability"The key drug industry associations have assured the government that there is enough stock of Active Pharmaceutical Ingredients APIs/ formu...
- Coronavirus: Department of Pharmaceuticals recommends ban on export of 12 drug formulations, ingredientsChina accounted for 67.56 per cent of India''s total imports of bulk drugs and drug intermediates at USD 2,405.42 million in 2018-19.
Load More
